Real-Life Benefit and Costs of First Line Pembroli-zumab for Advanced NSCLC—A Propensity-Score Matched Case-Control Study Vanessa Pirklbauer, Lea Friedrich,Romana Wass,Andreas Horner,Bernhard Kaiser, Bernd Lamprecht,David Langcrossref（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
